Biomerica, Inc. (BMRA)
Nasdaq: BMRA · In Vitro & In Vivo Diagnostic Substances · Irvine, CA · filing with the SEC since 1995
Who owns Biomerica, Inc.
As filed with the SECHolders of 5% or more
1
BRC Group Holdings, Inc. holds 10% of Common Stock, par value $0.08 per share, as its SCHEDULE 13D filed Aug 28, 2026 says.
Directors and officers
7
report now, of 15 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
BRC Group Holdings, Inc.
SCHEDULE 13D · filed Aug 28, 2026 · Common Stock, par value $0.08 per share
Wasatch Advisors LP
SCHEDULE 13G · filed Feb 11, 2025 · Common Stock · reported falling below 5%
What BMRA reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Polish Distributor
An investee · investee · invested in, named in the 10-K filed Aug 31, 2026
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 19 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Irani Zackary S. | Chief Executive Officer | 0 | $0 | 0 | 1 | $100,000 |
| Barbieri Allen | Executive Vice Chairman | 0 | $0 | 0 | 1 | $0 |
| Chin Eric | director | 0 | $0 | 0 | 1 | $0 |
| Gary M. Huff | director | 0 | $0 | 0 | 1 | $100,000 |
| Moatazedi David | director | 0 | $0 | 0 | 1 | $0 |